3M Beats Q3 Estimates, Guides FY26 EPS to $8.50–$8.70; Analysts Raise Targets
3M reported quarterly EPS of $1.83 versus $1.80 consensus on revenue of $6.13B (+1.5% YoY) and guided FY26 EPS to $8.50–$8.70. Morgan Stanley lifted its target to $165 and Deutsche Bank to $181 following the results, while Wells Fargo trimmed its target from $183 to $175.
1. Institutional Stake Surge by Cheviot Value Management
In the third quarter, Cheviot Value Management LLC expanded its position in 3M Company by 4,510%, acquiring an additional 4,510 shares to bring its total holding to 4,610 shares. At the end of the period, this stake was valued at approximately $769,000. Other institutional moves included OVERSEA CHINESE BANKING Corp Ltd increasing its position by 12% to 40,875 shares, Segall Bryant & Hamill LLC initiating a new stake valued at $8.6 million, and Knights of Columbus Asset Advisors LLC raising its holding by 2.1% to 77,624 shares. Overall, hedge funds and institutional investors now account for 65.25% of the company’s outstanding shares.
2. Quarterly Earnings Beat and Full-Year Guidance
3M reported fourth-quarter earnings per share of $1.83, surpassing the consensus estimate by $0.03, on revenue of $6.13 billion, which exceeded expectations by $100 million and represented a 1.5% increase year-over-year. Return on equity stood at 95.4% and net margin at 13.0%. Management reiterated full-year EPS guidance of $8.50 to $8.70, up from prior year’s $8.30, while forecasting organic sales growth of 3.0% for the coming year.
3. Dividend Policy and Payout Ratios
The company declared a quarterly dividend of $0.73 per share, paid to shareholders of record on November 14, translating to an annualized payout of $2.92 and a yield of 1.8%. With a dividend payout ratio of 48.7%, 3M maintains a commitment to returning capital while preserving investment capacity for research and development across its diversified portfolio.
4. Analyst Ratings and Consensus Outlook
Following the latest results, six research firms have maintained Buy ratings, four have Hold, and one has assigned a Sell rating, yielding a consensus ‘Hold’ stance. Recent target revisions include Morgan Stanley raising its price objective modestly, Deutsche Bank increasing its projection by $2, and Wells Fargo trimming its target by $8. The average analyst projection sits at 175.36, reflecting a balanced view of the company’s earnings momentum and macroeconomic headwinds.